Cytopeutics is a Malaysian stem cell company granted with several USA Patents for acute stroke, diabetes and macular oedema treatment with cell-based composition, as well as local patents for treatment involving heart, stroke, diabetes, autoimmune disease, critical limb ischemia and eye disease.
US Patent
US Patent for Acute Stroke
[No. 10,278,993]
US Patent for Diabetes
[No.11,052,119]
US Patent for Vernal Keratoconjunctivitis
[No. 10,828,332]
Malaysia Patents
Malaysia Patent for Heart
No. MY- 171690-A
Malaysia Patent for Stroke
No. MY-173966-A
Malaysia Patent for Diabetes
No. MY-171193-A
Malaysia Patent for Macular Oedema
No. MY-171311-A
Malaysia Patent for Vernal Keratoconjunctivitis
No. MY- 173386-A
Awards
Malaysia Health and Wellness Brand Awards
2017 – 2019
Endorsed by Ministry of Health, Malaysia
Brand Laureate Awards
2023 Brand ICON Leadership Award (Dr Chin SP)
2015-2016 SMEs Best Brands in Biotechnology Cell-Based Research & Treatment
Medical Technology – Health & Beauty Awards 2015-2016
by Long Life Magazine
SME 100 Awards 2015 Fast Moving Companies
by SME & Entrepreneurship Magazine
Grants
Ministry of Higher Education
FRGS 2010 – Kidney Research ERGS 2012 – Cardiomyopathy Treatment
SMARTFUND for Pioneering GVHD Treatment
Awarded by Ministry of Science
Technology, and Innovation (MOSTI)
